MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with R

Repaglinide

Repaglinide 1mg tablets

No stability information

Stability notes for Repaglinide 1mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Repaglinide 1mg tablets
Repaglinide 1mg tablets (A A H Pharmaceuticals Ltd)
Repaglinide 1mg tablets (Alliance Healthcare (Distribution) Ltd)
Repaglinide 1mg tablets (Krka UK Ltd)
Repaglinide 1mg tablets (Medihealth (Northern) Ltd)
Repaglinide 1mg tablets (Rivopharm (UK) Ltd)
Repaglinide 1mg tablets (Viatris UK Healthcare Ltd)

Repaglinide 2mg tablets

No stability information

Stability notes for Repaglinide 2mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Repaglinide 2mg tablets
Repaglinide 2mg tablets (A A H Pharmaceuticals Ltd)
Repaglinide 2mg tablets (Accord-UK Ltd)
Repaglinide 2mg tablets (Alliance Healthcare (Distribution) Ltd)
Repaglinide 2mg tablets (Medihealth (Northern) Ltd)
Repaglinide 2mg tablets (Rivopharm (UK) Ltd)
Repaglinide 2mg tablets (Viatris UK Healthcare Ltd)

Repaglinide 500microgram tablets

No stability information

Stability notes for Repaglinide 500microgram tablets

There are no stability notes for this medicine.

Suppliers (5) of Repaglinide 500microgram tablets
Repaglinide 500microgram tablets (A A H Pharmaceuticals Ltd)
Repaglinide 500microgram tablets (Alliance Healthcare (Distribution) Ltd)
Repaglinide 500microgram tablets (Krka UK Ltd)
Repaglinide 500microgram tablets (Medihealth (Northern) Ltd)
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.